CHRDL1 Monoclonal Antibody

Sizes: 50µl, 100µl

Catalogue Numbers: MB0127-50, MB0127-100

Product: 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2

Swiss-Prot: Q9BU40

Host: Mouse IgG1

Reactivity: Human, Mouse, Rat

Applications: WB, ICC

All Applications: WB: 1:1000
ICC: 1:300

Background: This gene encodes an antagonist of bone morphogenetic protein 4. The encoded protein may play a role in topographic retinotectal projection and in the regulation of retinal angiogenesis in response to hypoxia. Alternatively spliced transcript variants encoding different isoforms have been described. Antagonizes the function of BMP4 by binding to it and preventing its interaction with receptors. Alters the fate commitment of neural stem cells from gliogenesis to neurogenesis. Contributes to neuronal differentiation of neural stem cells in the brain by preventing the adoption of a glial fate. May play a crucial role in dorsoventral axis formation. May play a role in embyonic bone formation By similarity. May also play an important role in regulating retinal angiogenesis trough modulation of BMP4 actions in endothelial cells.

Purification and Purity: The antibody was affinity-purified from mouse ascites by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).

Storage and Stability: Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Specificity: CHRDL1 mAb detects endogenous levels of CHRDL1 protein.

Bioworld Molecular Weight: Predicted band size: 57kDa
Observed band size: 57kDa

Note: For research use only, not for use in diagnostic procedure.

Extra Notes: Western blot detection of CHRDL1 in Rat kidney tissue lysates using CHRDL1 antibody (1:1000 diluted)., Immunocytochemistry stain of Hela using CHRDL1 antibody (1:300).

Alternative Name: Neuralin-1 Neurogenesin-1 Ventroptin; CHL; VOPT; NRLN1; dA141H5.1

Immunogen: Recombinant full length Human CHRDL1.

Conjugate: Unconjugated

Modification: Unmodified